The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nu (Q44980861)
Jump to navigation
Jump to search
scientific article published on 15 July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nu |
scientific article published on 15 July 2004 |
Statements
1 reference
The NR2B-selective N-methyl-D-aspartate receptor antagonist Ro 25-6981 [(+/-)-(R*,S*)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine propanol] potentiates the effect of nicotine on locomotor activity and dopamine release in the nu (English)
1 reference
Alexander R Kosowski
1 reference
Sture Liljequist
1 reference
15 July 2004
1 reference
1 reference
311
1 reference
2
1 reference
560-567
1 reference
Identifiers
1 reference
1 reference